Literature DB >> 17612417

Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies.

L Coudeville1, A van Rie, P Andre.   

Abstract

A compartmental, age-structured mathematical model was developed and recent US pertussis epidemiology data were used to evaluate the impact on pertussis infection rates of routine and targeted adult immunization strategies. Model simulations predict that the implementation of adolescent immunization only could reverse the current rise in pertussis infection rates but may lead to a resurgence of pertussis in subsequent decades. In contrast, inclusion of a routine adult strategy is likely to lead to sustained control of pertussis. Routine adult vaccination could control the disease even with relatively low coverage rates of 40% for routine vaccination of all adults every 10 years, or 65% for a targeted vaccination of close contacts of newborns completed by one booster dose for all adults. The model also predicts that the optimal age for this booster dose is 40 years. These results support the 2006 American Academy of Immunization Practices' recommendations for adolescent and adult vaccination against pertussis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612417      PMCID: PMC2870855          DOI: 10.1017/S0950268807009041

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  17 in total

1.  Measles dynamics and vaccination diffusion. A model and an application.

Authors:  Laurent Coudeville
Journal:  Eur J Health Econ       Date:  2003-11

2.  Summary of notifiable diseases--United States, 2004.

Authors:  Ruth Ann Jajosky; Patsy A Hall; Deborah A Adams; Felicia J Dawkins; Pearl Sharp; Willie J Anderson; J Javier Aponte; Gerald F Jones; David A Nitschke; Carol A Worsham; Nelson Adekoya; Timothy Doyle
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-06-16       Impact factor: 17.586

3.  Pertussis in adolescents and adults: should we vaccinate?

Authors:  Grace M Lee; Charles Lebaron; Trudy V Murphy; Susan Lett; Stephanie Schauer; Tracy A Lieu
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

4.  An age-structured model for pertussis transmission.

Authors:  H W Hethcote
Journal:  Math Biosci       Date:  1997-10-15       Impact factor: 2.144

5.  Efficacy of an acellular pertussis vaccine among adolescents and adults.

Authors:  Joel I Ward; James D Cherry; Swei-Ju Chang; Susan Partridge; Hang Lee; John Treanor; David P Greenberg; Wendy Keitel; Stephen Barenkamp; David I Bernstein; Robert Edelman; Kathryn Edwards
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

6.  [Epidemiological estimation of the effectiveness of the pertussis vaccination during outbreaks in a community. Les pédiatres et bactériologistes du réseau RENACOQ].

Authors:  S Baron; E Grimprel; G Daurat; C Cuisinet; A Ponge; S Haeghebaert; N Guiso; J C Desenclos; J Drucker
Journal:  Arch Pediatr       Date:  1997-08       Impact factor: 1.180

7.  Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Authors:  Kristine M Bisgard; Philip Rhodes; Beverly L Connelly; Daoling Bi; Christine Hahn; Sarah Patrick; Mary P Glodé; Kristen R Ehresmann
Journal:  Pediatrics       Date:  2005-08       Impact factor: 7.124

8.  Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis.

Authors:  Kenneth W Purdy; Joel W Hay; Marc F Botteman; Joel I Ward
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

9.  Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Karen R Broder; Margaret M Cortese; John K Iskander; Katrina Kretsinger; Barbara A Slade; Kristin H Brown; Christina M Mijalski; Tejpratap Tiwari; Emily J Weston; Amanda C Cohn; Pamela U Srivastava; John S Moran; Benjamin Schwartz; Trudy V Murphy
Journal:  MMWR Recomm Rep       Date:  2006-03-24

10.  Infant pertussis: who was the source?

Authors:  Kristine M Bisgard; F Brian Pascual; Kristen R Ehresmann; Claudia A Miller; Christy Cianfrini; Charles E Jennings; Catherine A Rebmann; Julie Gabel; Stephanie L Schauer; Susan M Lett
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129

View more
  14 in total

1.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

2.  Hospitalizations for pertussis in Italy, 1999-2009: analysis of the hospital discharge database.

Authors:  Giovanni Gabutti; Maria Cristina Rota; Bernardo Bonato; Roberta Pirani; Giuliana Turlà; Alessandro Cucchi; Alessandra Cavallaro
Journal:  Eur J Pediatr       Date:  2012-07-13       Impact factor: 3.183

3.  Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.

Authors:  Joanne Embree; Barbara Law; Tim Voloshen; Antigona Tomovici
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

4.  Protecting infants from pertussis.

Authors:  Meghan Gilley; Ran D Goldman
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

Review 5.  Prevention of pertussis through adult vaccination.

Authors:  Manika Suryadevara; Joseph B Domachowske
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Increased awareness and health care provider endorsement is required to encourage pregnant women to be vaccinated.

Authors:  J Collins; I Alona; R Tooher; H Marshall
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

7.  Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States.

Authors:  Katherine E Atkins; Meagan C Fitzpatrick; Alison P Galvani; Jeffrey P Townsend
Journal:  Am J Epidemiol       Date:  2016-05-13       Impact factor: 4.897

8.  Modelling the impact of extended vaccination strategies on the epidemiology of pertussis.

Authors:  M H Rozenbaum; R De Vries; H H LE; M J Postma
Journal:  Epidemiol Infect       Date:  2011-11-24       Impact factor: 2.451

9.  Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects.

Authors:  Laurent Coudeville; Annelies Van Rie; Denis Getsios; J Jaime Caro; Pascal Crépey; Van Hung Nguyen
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

Review 10.  Pertussis: a review of disease epidemiology worldwide and in Italy.

Authors:  Giovanni Gabutti; Maria Cristina Rota
Journal:  Int J Environ Res Public Health       Date:  2012-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.